PH31258A - New use of ropivacaine. - Google Patents

New use of ropivacaine.

Info

Publication number
PH31258A
PH31258A PH48413A PH48413A PH31258A PH 31258 A PH31258 A PH 31258A PH 48413 A PH48413 A PH 48413A PH 48413 A PH48413 A PH 48413A PH 31258 A PH31258 A PH 31258A
Authority
PH
Philippines
Prior art keywords
pct
ropivacaine
new use
sec
date
Prior art date
Application number
PH48413A
Other languages
English (en)
Inventor
Eek Arne Toraka
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH31258(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of PH31258A publication Critical patent/PH31258A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
PH48413A 1993-06-28 1994-06-09 New use of ropivacaine. PH31258A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Publications (1)

Publication Number Publication Date
PH31258A true PH31258A (en) 1998-06-18

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
PH48413A PH31258A (en) 1993-06-28 1994-06-09 New use of ropivacaine.

Country Status (33)

Country Link
US (2) US5670524A (zh)
EP (1) EP0706395B1 (zh)
JP (1) JP3725541B2 (zh)
CN (1) CN1074918C (zh)
AT (1) ATE216237T1 (zh)
BR (1) BR9406865A (zh)
CA (1) CA2165446C (zh)
CZ (1) CZ283300B6 (zh)
DE (2) DE69430427T2 (zh)
DK (1) DK0706395T3 (zh)
EE (1) EE03205B1 (zh)
ES (1) ES2099048T3 (zh)
FI (1) FI956269A0 (zh)
GR (1) GR970300013T1 (zh)
HK (1) HK1010344A1 (zh)
HU (1) HU218949B (zh)
IL (1) IL110006A (zh)
IS (1) IS4174A (zh)
LT (1) LT3449B (zh)
LV (1) LV12918B (zh)
MY (1) MY119360A (zh)
NO (1) NO955313L (zh)
NZ (1) NZ268110A (zh)
PH (1) PH31258A (zh)
PL (1) PL175518B1 (zh)
PT (1) PT706395E (zh)
RU (1) RU2152215C1 (zh)
SA (1) SA94150010B1 (zh)
SE (1) SE9302218D0 (zh)
SG (1) SG49078A1 (zh)
SK (1) SK280111B6 (zh)
TW (1) TW285640B (zh)
WO (1) WO1995000148A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
BR9802536A (pt) * 1997-07-21 1999-07-20 Darwin Discovery Ltd Método para anestesiar um paciente humano antes de cirurgias
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
CA2871821C (en) 2012-05-10 2021-01-12 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
JP2016508956A (ja) * 2012-05-10 2016-03-24 セリックスビオ プライヴェート リミテッド 局所疼痛の治療のための組成物と治療法
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
EP2961734B1 (en) 2013-02-28 2018-09-26 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE40994T1 (de) * 1983-08-01 1989-03-15 Astra Laekemedel Ab L-n-n-propylpipekolsaeure-2,6-xylidid und dessen herstellung.
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
WO1995000148A1 (en) 1995-01-05
DK0706395T3 (da) 2002-07-22
ES2099048T3 (es) 2002-11-16
HU218949B (hu) 2001-01-29
FI956269A (fi) 1995-12-27
JP3725541B2 (ja) 2005-12-14
LT3449B (en) 1995-10-25
HUT75115A (en) 1997-04-28
GR970300013T1 (en) 1997-05-31
RU2152215C1 (ru) 2000-07-10
EE03205B1 (et) 1999-08-16
SA94150010B1 (ar) 2006-04-04
CA2165446A1 (en) 1995-01-05
IS4174A (is) 1994-12-29
JPH09500620A (ja) 1997-01-21
TW285640B (zh) 1996-09-11
CZ283300B6 (cs) 1998-02-18
CN1126435A (zh) 1996-07-10
NZ268110A (en) 1999-06-29
SK280111B6 (sk) 1999-08-06
NO955313D0 (no) 1995-12-27
AU7086694A (en) 1995-01-17
DE69430427T2 (de) 2002-11-14
AU692161B2 (en) 1998-06-04
HK1010344A1 (en) 1999-06-17
ATE216237T1 (de) 2002-05-15
FI956269A0 (fi) 1995-12-27
LV12918B (en) 2003-03-20
PT706395E (pt) 2002-09-30
HU9503692D0 (en) 1996-02-28
SK164695A3 (en) 1996-07-03
EP0706395B1 (en) 2002-04-17
US5670524A (en) 1997-09-23
LTIP1958A (en) 1995-01-31
SE9302218D0 (sv) 1993-06-28
NO955313L (no) 1995-12-27
BR9406865A (pt) 1996-03-26
CA2165446C (en) 2005-07-05
CZ336495A3 (en) 1996-06-12
IL110006A (en) 1999-01-26
EP0706395A1 (en) 1996-04-17
MY119360A (en) 2005-05-31
SG49078A1 (en) 1998-05-18
PL312198A1 (en) 1996-04-01
IL110006A0 (en) 1994-11-11
DE69430427D1 (de) 2002-05-23
ES2099048T1 (es) 1997-05-16
PL175518B1 (pl) 1999-01-29
CN1074918C (zh) 2001-11-21
US5834489A (en) 1998-11-10
DE706395T1 (de) 1997-09-04

Similar Documents

Publication Publication Date Title
IL113631A0 (en) New antagonist compounds
ZA944934B (en) New pharmaceutical formulation
TW285640B (zh)
CA2181225A1 (en) The use of sertraline to treat post myocardial infarction patients
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
IL122853A0 (en) Use of allylamines
HUT72329A (en) Application of riluzole as a radiorestorer